Aditya Shreenivas, M.D., M.S.
- Gastrointestinal Cancers
- Colorectal Cancer
- Head and Neck Cancers
- Assistant Professor, Department of Medical Oncology & Therapeutics Research
Board-certified in hematology and oncology, Aditya Shreenivas, M.D., M.S., takes an individualized approach to treating cancer with leading-edge options, with a particular focus on gastrointestinal cancers and head and neck cancers. As a researcher, he focuses on studying innovative therapeutics and pioneering new approaches to precision medicine.
Dr. Shreenivas was inspired to become a doctor by his grandfather – a physician who founded India’s Indira Gandhi Institute of Cardiology – and his mother, a renowned obstetrician and gynecologist. He earned his medical degree at JSS Medical School in Mysuru, India, then completed a residency in internal medicine at Bronx-Lebanon Medical Center and a fellowship in hematology-oncology at Icahn School of Medicine at Mount Sinai, where he also earned a master’s degree in clinical research.
Dr. Shreenivas will also be affiliated with City of Hope's experimental therapeutics and early drug development program. He believes in the concept of vertical research, and the overall thrust of his research work has been focused on creating a small but significant impacts in the field of oncology. Dr. Shreenivas remains committed to a career focused on symptom management, experimental therapeutics, and precision medicine. He has co-authored several peer-reviewed articles, which have been published in journals like CA: A Cancer Journal for Clinicians and JCO-Precision Oncology, European Journal of Cancers and Blood, among others.
Before joining City of Hope, Dr. Shreenivas was an assistant professor of hematology-oncology at the Medical College of Wisconsin in Milwaukee, where he specialized in head and neck, gastrointestinal and rare cancers. Actively involved in clinical and translational research, he has grant funding from NRG Oncology and served as principal investigator of multiple industry-sponsored and investigator-initiated clinical trials.
Location
Duarte Cancer Center
Duarte, CA 91010
Education & Experience
- 2018, American Board of Internal Medicine, Hematology
- 2018, American Board of Internal Medicine, Oncology
- 2015, American Board of Internal Medicine, certified
- 2018, Master of Science, Clinical Research, Icahn School of Medicine, New York, NY
- 2010, Doctor of Medicine, JSS Medical College, Mysore, India
- 2018, Fellowship, Hematology-Oncology, Mt. Sinai Medical Center, Icahn School of Medicine, New York, NY
- 2015, Residency, BronxCare Health System, Bronx, NY
- 2013, Internship, BronxCare Health System, Bronx, NY
- 2024-Present, Assistant Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
- 2019-2024, Assistant Professor, Department of Medical Oncology, Medical College of Wisconsin, Milwaukee, WI
Awards & Memberships
- 2023, Listed among Milwaukee’s top oncologists in 2022 in the June 2023 edition of The Waiting Room Magazine
- 2020, NRG NCORP pilot grant recipient
- 2018, Awarded Master of Science in Clinical Research Best Thesis Award for the academic year at the Mount, Sinai Achievement Award Ceremony
- Young Investigator Committee Head and Neck Cancer International Group
- Alliance Gastrointestinal Cancer Committee
- NRG Head & Neck Rare Cancer Committee
- Alliance Symptom Intervention Committee
- ECOG Symptom Intervention Committee
Publications
- Characterization of an Oligometastatic State in Patients with Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy accepted for publication in the journal Cancer Medicine on 13th September 2023 (Ortiz D E., Visotsky A., Shreenivas A.V.,….Hall W.)
- ALK fusions in the pan-cancer setting: Another tumor-agnostic target?" accepted for publication in npj Precision Oncology 25th August 2023 (Shreenivas A. V., Janku F., Kato S., Kurzrock R.)
- Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer. (Matoska T, Banerjee A, Shreenivas A…Puckett L). published in Cancers (Basel). 2023 Apr 28;15(9):2523. doi: 10.3390/cancers15092523
- Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. (Tahir S., Calvo E., Shreenivas A.,… Phillips D.) published in Blood. 2023 Jan 30:blood.2022017333. doi: 10.1182/blood.2022017333.
- Genomic profiling and precision medicine in complex ameloblastoma. (Gates J., Shreenivas AV., Kraus D, Ross J) published in Head Neck. 2023 Apr;45(4):816-826. doi: 10.1002/hed.27294. Epub 2023 Jan 16.
- Blood And Marrow Transplant Within Four Weeks of SARS-CoV-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study: accepted for publication in the journal Bone Marrow Transplantation 2023; (Mohan M, Kothari A, Shreenivas A., D’Souza A.)
- Carcinoma of unknown primary: Molecular tumor board-based therapy; (Shreenivas, A.V., Kato, S., Hu, J., ...Sicklick, J., Kurzrock, R.) published in CA Cancer Journal for Clinicians, Aug 2022 DOI: 10.3322/caac.21748
- Book Chapter on Testicular cancer (Shreenivas A.V., Seth M Cohen MD) published in MSSM expert guides: oncology https://doi.org/10.1002/9781119189596.ch5.
- Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (Kamgar, M., Chakrabarti, S., Shreenivas, A.V., George, B.) review published in Surgical Oncology Clinics of North America, 2021, 30(4), pp. 673– 691 DOI: 10.1016/j.soc.2021.06.004
- Frequent omission of radiation after flap reconstruction of head and neck cancer: Are we dooming patients to failure? (North, L.M., Harvey, E., Vanle B., ...Shreenivas A.V., Awan, M., Zenga, J.) published in Oral Oncology, DOI: 10.1016/j.oraloncology.2021.105225.
- A closer look at 30-day hospital readmissions after head and neck cancer surgery (Puccia, R., Shreenivas A.V., Zenga, J.) published in American Journal of Otolaryngology DOI:10.1016/j.amjoto.2021.103146.
- Excellent response with alpelisib and bicalutamide for advanced salivary duct carcinoma with PIK3CA mutation and high androgen receptor expression-A case report (Sheth, H., Kumar, P., Shreenivas, A.V., ...Datar, R., Limaye, S.) JCO Precision Oncology, 2021, DOI: 10.1200/PO.20.00436.
- Reply to S. Cavalieri et al (Limaye, S., Kumar, P., Datar, R., Shreenivas, A.V) published in JCO Precision Oncology, 2021, DOI: 10.1200/PO.21.00353.
- Oral mucositis—case series of a rare adverse effect associated with immunotherapy (Sheth, H., Pragya, R., Kovale, S., ...Shreenivas, A.V, Limaye, S.) published in Supportive Care in Cancer, 2021, DOI: 10.1007/s00520-02105993-5.
- Hepatocellular Carcinoma: Western Experience Image-Guided Interventions in Oncology pp 81-118 (Maguire T.J., Shreenivas A.V., Rilling W.S.) published in Hepatocellular Carcinoma: Western Experience. In: Georgiades C., Kim H. (eds) Image-Guided Interventions in Oncology. Springer, Cham. https://doi.org/10.1007/978-3- 03048767-6_6 07/29/2020
- Central Nervous System Metastases in Triple Negative Breast Cancer: A Step in the Right Direction. (Shreenivas A.V., Shapiro C) editorial published in the Breast Journal 2019 DOI: 10.1111/tbj.13232
- Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. (North L, Stadler M, Shreenivas A.V., Zenga J.) et Al published in Am J Otolaryngology. 2019 Sep 6:102282: DOI: 10.1016/j.amjoto.2019.102282.
- Y, Petriček I, Shreenivas A.V., Nuria S. et Al published in Bone Marrow Transplant. 2019 DOI: 10.1038/s41409-018-0339-6.
- Lymph Node Yield, Depth of Invasion, and Survival in Node-Negative Oral Cavity Cancer (Zenga J, Wong S, Shreenivas A.V., Pipkorn et Al.) published in Journal of oral oncology DOI: 10.1016/j.oraloncology.2019.09.028.
- Who knows the nose? – The Tale of Esthesioneuroblastomas and Sinonasal Neuroendocrine Carcinoma published in the Journal Cancer Research, Statistics, and Treatment (Limaye S., Shreenivas A.V.) DOI: 10.4103/CRST.CRST_122_20
To view more publications, please click here.